The denial of Zealand Pharma’s medication prospect for the therapy of brief digestive tract disorder by United States authorities does not modify the business’s strategies to get authorization in Europe.
发布者：BY ALBERT RONNING-ANDERSSON，转转请注明出处：https://robotalks.cn/zealand-pharma-ceo-after-fda-rejection-we-are-hugely-disappointed/
Tim Bucher is the cofounder and CEO of Agtonomy, a California-based, software, services and technology company enabling autonomy in agriculture. Bucher purchased his own land at 16…
Ralf-Peter Sch fer, TomTom VP of Item Monitoring Web Traffic and Traveling Info, has actually researched web traffic, blockage and its influence on transportation for years. Over t…
In 2024, we were really reserved, relished brat summertime, and loved an audacious pygmy hippo, all while sustaining services of all dimensions that substantially add to the United…
Researchers have actually recognized stress of among the globe’s most hazardous fungal virus, currently immune to our most efficient antifungal medicines, which are additiona…
Volkswagen’s “ID. Buzz” electrical van at the Lumen Area Occasion Facility throughout the Seattle International Car Program on Thursday. (GeekWire Picture/ Kurt S…
